Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid caseload to ensure smooth and fast delivery of the medicine, the centre said in a statement. The statement also mentioned the production capacity is being ramped up from current level of 38 lakh vials per month to 74 lakh vials per month, and 20 additional manufacturing sites have been approved. &lsquo;Export of remdesivir has also been prohibited in order to shore up domestic supplies&rsquo; it said.
The Health Ministry and the Department of Pharmaceuticals have made an interim allocation of remdesivir for 19 states and UTs up to April 30. "This allocation pertains to 14 states to which medical oxygen is allocated and five other states where the high volume of supplies are being observed," the centre said.

For faster supply of Covid drug Remdesivir, 19 states mapped with manufacturers

For faster supply of Covid drug Remdesivir 19 states with manufacturers mapped

Demand for Remdesivir&nbsp;increases in light of covid&nbsp;wave
Centre&nbsp;maps manufacturers to ensure delivery of medicine
Health Ministry allocates remdesivir for 19 states and UTs

The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid caseload to ensure smooth and fast delivery of the medicine, the centre said in a statement. The statement also mentioned the production capacity is being ramped up from current level of 38 lakh vials per month to 74 lakh vials per month, and 20 additional manufacturing sites have been approved. &lsquo;Export of remdesivir has also been prohibited in order to shore up domestic supplies&rsquo; it said.
The Health Ministry and the Department of Pharmaceuticals have made an interim allocation of remdesivir for 19 states and UTs up to April 30. "This allocation pertains to 14 states to which medical oxygen is allocated and five other states where the high volume of supplies are being observed," the centre said.

remdesivir production

Categories